<DOC>
	<DOCNO>NCT00400985</DOCNO>
	<brief_summary>The SENSE-HF study prospective , observational , international multi-center study prospectively evaluate sensitivity positive predictive value OptiVol Fluid Trends data predict HF-related hospitalization health care utilization associate sign and/or symptom pulmonary congestion , define OptiVol clinical guideline subject therapy management .</brief_summary>
	<brief_title>Sensitivity InSync Sentry OptiVol Feature Prediction Heart Failure</brief_title>
	<detailed_description>The SENSE-HF study prospectively evaluate OptiVol feature prediction HF-related event associate sign symptom pulmonary congestion subject HF therapy management . The OptiVol feature base measurement daily intrathoracic impedance value , measurement use track change subject 's thoracic fluid status time . An Alert warn patient whenever programmable threshold reach . The study divide three phase . The first phase double-blinded design determine sensitivity positive predictive value OptiVol Fluid Trends data detection Heart Failure relate hospitalization sign and/or symptoms pulmonary congestion . In second phase study , Alert turn ON positive predictive value first OptiVol Patient Alert development sign and/or symptom pulmonary congestion evaluate . The third phase study allow remote subject therapy management use OptiVol Patient Alert . The patient management strategy base experience gain second study phase Physician action take occurrence Patient Alert summarize .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Successfully implant InSync Sentry device ( &lt; 34 day post implant pocket revision ) pectoral region ; At least one HFrelated hospitalization require administration IV medication ( inotropes , nitrate , diuretic ) within last 12 month The Subject market release , transvenous , high voltage RV lead The Subject able detect Patient Alert signal &lt; 18 year age ( minimum age require local law ) Moderate severe Chronic Obstructive Pulmonary Disease ( COPD ) Post heart transplant await heart transplantation Primary pulmonary hypertension Renal insufficiency require dialysis Amendment inclusion criterion ( Jul 06 ) : Inclusion patient Concerto/Virtuoso device . At least one HFrelated hospitalization require administration IV ( uptitration oral medication ) ( inotropes , nitrate , diuretic ) within last 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Heart Failure , Congestive</keyword>
	<keyword>Diagnostic</keyword>
	<keyword>Ambulatory Monitoring</keyword>
	<keyword>Intrathoracic Impedance</keyword>
</DOC>